Blood Transfusion Diagnostics Global Market Report Blood Transfusion Diagnostics Global Market Report 2023 – By Type (Instruments and Kits, Reagents, Other Types), By End User – (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies), By Technology – (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening) – Market Size, Trends, And Market Forecast 2023-2032 ...(expand)

Blood transfusion diagnostics are used to conduct tests before the transfusion of blood from donor-recipient such as blood grouping disease screening. For further insights on the blood transfusion diagnostics market, request a sample here

The blood transfusion diagnostics market growth is aided by increase in the number of surgical procedures. However, some blood transfusion diagnostics market restraints include lack adequate blood banks, proper medical equipment for blood transfusion, adequate conditions for the storage of blood, and low supply for the high demand of blood in developing and underdeveloped countries. For further insights on the blood transfusion diagnostics market, request a sample here

The blood transfusion diagnostics market is expected to reach $5.68 billion in 2027 at a rate of 9.3%. For further insights on the blood transfusion diagnostics market, request a sample here

The global blood transfusion diagnostics market is segmented as
1) By Type: Instruments and Kits, Reagents, Other Types
2) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
3) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test
4) By Application: Blood Grouping, Disease Screening
For further insights on the blood transfusion diagnostics market, request a sample here

North America was the largest region in the blood transfusion diagnostics market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Key competitors in the blood transfusion diagnostics market are, BAG Health Care GmbH, Grifols, Bio-Rad LaboratoriesInc., Abbott Laboratories, ImmucorInc, Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Beckman CoulterInc., Novartis AG, F. Hoffmann-La Roche Ltd., Quotient Limited, HologicInc, Roche Diagnostics, bioMerieux, Diagast, Fujirebio, Biokit, Quidel, Hologic/Gen-Probe, Becton Dickinson and Company, Proteomes Sciences, Danaher Corporation. For further insights on the blood transfusion diagnostics market, request a sample here.

Major trends influencing the blood transfusion diagnostics market include growing demand for advanced diagnostic measures and growing prevalence of infectious diseases associated with pathogens such as bacteria & viruses increase the preference for nucleic acid amplification testing (NAAT/NAT) to increase blood safety, improve efficiency and reduce the turnaround time of the results. NAT is a technique that helps detect a particular nucleic acid, virus, or bacteria that acts as a pathogen in blood, tissue, or urine. NAT is highly sensitive and specific for viral nucleic acids and amplifies the region of targeted viral DNA and detects them earlier than the other traditional methods and narrows the period of infectious diseases. For further insights on the blood transfusion diagnostics market, request a sample here.

For detailed insights on the major opportunities and strategies in the blood transfusion diagnostics market, request a sample here.

For detailed insights on blood transfusion diagnostics market's relation to the overall economy and other similar markets, request a sample here.

For detailed insights on the mergers and acquisitions in the blood transfusion diagnostics industry, request a sample here.

For detailed insights on the key dynamics influencing the blood transfusion diagnostics market growth and SWOT analysis of the blood transfusion diagnostics industry, request a sample here.